ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,101.24
      -0.29%
      US Tech 100
      21,156.80
      -0.70%
      Dow Jones
      44,424.25
      -0.32%
      Brent Oil
      77.625
      0.00%
      Bitcoin
      104,503.11
      -0.22%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tonix Pharmaceuticals Holding Corporation (TNXP) Quote

      Tonix Pharmaceuticals Holding Corporation

      Tonix Pharmaceuticals Holding Corporation (TNXP)

      NASDAQ
      0.3831
      0.0556
      (16.98%)
      Closed January 26 4:00PM
      Delayed by 15 minutes
      0.3725
      -0.0106
      (-2.77%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.3725
      Bid
      0.37
      Ask
      0.3725
      Volume
      185,189,935
      0.341 Day's Range 0.42
      0.118 52 Week Range 12.48
      Market Cap
      69.618M
      Previous Close
      0.3275
      Open
      0.3493
      Last Trade
      100
      @
      0.3725
      (formt)
      Last Trade Time
      Financial Volume
      $ 71,121,361
      VWAP
      0.384046
      Average Volume (3m)
      120,585,392
      Shares Outstanding
      186,894,225
      Dividend Yield
      -
      PE Ratio
      -0.61
      Earnings Per Share (EPS)
      -0.62
      Revenue
      7.77M
      Net Profit
      -116.66M

      About Tonix Pharmaceuticals Holding Corporation

      Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious dise... Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.tonixpharma.com
      Headquarters
      Carson City, Nevada, USA
      Founded
      -
      Tonix Pharmaceuticals Holding Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNXP. The last closing price for Tonix Pharmaceuticals was $0.33. Over the last year, Tonix Pharmaceuticals shares have traded in a share price range of $ 0.118 to $ 12.48.

      Tonix Pharmaceuticals currently has 186,894,225 shares outstanding. The market capitalization of Tonix Pharmaceuticals is $61.21 million. Tonix Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.61.

      Ask ADVFN Intelligence (AI)

      TNXP Latest News

      More News

      Form 8-K - Current report

      January 08 2025
      Edgar (US Regulatory)

      Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

      Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration (FDA) recently assigned a Prescription Drug User Fee Act (PDUFA) goal...

      January 08 2025
      GlobeNewswire Inc.

      Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

      CHATHAM, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of...

      January 07 2025
      GlobeNewswire Inc.

      Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      January 03 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 23 2024
      Edgar (US Regulatory)

      Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

      Tonix received FDA’s Day 74 Letter granting TNX-102 SL a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025 TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast...

      December 23 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      December 20 2024
      Edgar (US Regulatory)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      December 20 2024
      Edgar (US Regulatory)

      This Micro Cap Is Getting Bid Up Prior To Opening Bell

      A New Jersey-based biotech company is finding quite a bit of success so far during Tuesday’s premarket hours after the company said that the US Food and Drug Administration To read the full...

      December 17 2024
      AllPennyStocks.com

      Form 8-K - Current report

      December 17 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.142561.95652173910.230.40.22061003934970.29850533CS
      40.02256.428571428570.350.4250.216785968780.29708305CS
      120.2246151.8593644350.14791.30.12641205853920.37115882CS
      26-0.2276-37.92701216460.60011.30.118687136020.3440116CS
      52-8.9235-95.99290017219.29612.480.118358648060.51347932CS
      156-41.6275-99.1130952381429580.1181683062938.75434958CS
      260-363.6275-99.89766483523649580.11816651662100.89697656CS

      TNXP - Frequently Asked Questions (FAQ)

      What is the current Tonix Pharmaceuticals share price?
      The current share price of Tonix Pharmaceuticals is $ 0.3725
      How many Tonix Pharmaceuticals shares are in issue?
      Tonix Pharmaceuticals has 186,894,225 shares in issue
      What is the market cap of Tonix Pharmaceuticals?
      The market capitalisation of Tonix Pharmaceuticals is USD 61.21M
      What is the 1 year trading range for Tonix Pharmaceuticals share price?
      Tonix Pharmaceuticals has traded in the range of $ 0.118 to $ 12.48 during the past year
      What is the PE ratio of Tonix Pharmaceuticals?
      The price to earnings ratio of Tonix Pharmaceuticals is -0.61
      What is the cash to sales ratio of Tonix Pharmaceuticals?
      The cash to sales ratio of Tonix Pharmaceuticals is 9.13
      What is the reporting currency for Tonix Pharmaceuticals?
      Tonix Pharmaceuticals reports financial results in USD
      What is the latest annual turnover for Tonix Pharmaceuticals?
      The latest annual turnover of Tonix Pharmaceuticals is USD 7.77M
      What is the latest annual profit for Tonix Pharmaceuticals?
      The latest annual profit of Tonix Pharmaceuticals is USD -116.66M
      What is the registered address of Tonix Pharmaceuticals?
      The registered address for Tonix Pharmaceuticals is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
      What is the Tonix Pharmaceuticals website address?
      The website address for Tonix Pharmaceuticals is www.tonixpharma.com
      Which industry sector does Tonix Pharmaceuticals operate in?
      Tonix Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NVNINVNI Group Ltd
      $ 4.38
      (193.96%)
      		366.98M
      EVAXEvaxion Biotech AS
      $ 5.99
      (64.56%)
      		55.41M
      ELABPMGC Holdings Inc
      $ 3.0901
      (56.07%)
      		76.48M
      PCLAPicoCELA Inc
      $ 4.60
      (49.35%)
      		3.75M
      GOEVCanoo Inc
      $ 0.475
      (43.94%)
      		282.22M
      GODNUGolden Star Acquisition Corporation
      $ 3.11
      (-75.82%)
      		17.51k
      GODNGolden Star Acquisition Corporation
      $ 2.93
      (-65.67%)
      		902.76k
      NXTTNext Technology Holding Inc
      $ 1.37
      (-54.93%)
      		2.56M
      SGLYSingularity Future Technology Ltd
      $ 1.625
      (-38.45%)
      		917.77k
      WHLRLWheeler Real Estate Investment Trust Inc
      $ 90.11
      (-38.07%)
      		8
      ACONAclarion Inc
      $ 0.0557
      (28.94%)
      		811.91M
      NVNINVNI Group Ltd
      $ 4.38
      (193.96%)
      		366.98M
      RIMEAlgorhythm Holdings Inc
      $ 0.0357
      (4.69%)
      		284.97M
      GOEVCanoo Inc
      $ 0.475
      (43.94%)
      		282.22M
      NVDANVIDIA Corporation
      $ 142.62
      (-3.12%)
      		232.88M

      TNXP Discussion

      View Posts
      Stino2 Stino2 1 hour ago
      I have 200.000 on 59 cent, so if I sell, I lose 😪
      👍️0
      green maschine green maschine 4 hours ago
      It also depends on when one can begin trading in pre. We could use a couple of gap ups this week.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 5 hours ago
      All you made is $6300 with a 20% price change, you don’t have a lot of shares.
      Guessing no more than 90,000 shares.
      Looking at the technical charts, it’s pointing up.
      1st time in a long time closed above the 150dma.
      Time will tell, if it was a smart move or how big of a pile you left behind.
      But that’s what day traders do.
      Look at any of the high flyers, including the top few, see how low they were not long ago.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 5 hours ago
      No, based on $6300 with a 20% price change, you don’t have a lot of shares.
      Guessing no more than 90,000 shares.
      👍️0
      green maschine green maschine 5 hours ago
      Is that 69,078 shares? Just testing my math.
      👍️0
      insidernews insidernews 8 hours ago
      I did sell Friday only because I had 20% gain and a lot of shares. Right when I checked it was near 42 cents. I sold at the top @4187 glad I did saved me $3500. Up $6300 for the day. That being said I will be buying back in the only thing that has me concerned is that February 5th deadline. Follow the money that's what I always say. This has been trading with a lot of money back and forth. The percentage gains that this could make is worth the risk. Going to be a bumpy ride till August 15th.
      👎️ 1
      Stino2 Stino2 11 hours ago
      It is not normal that there are so many SHORTS!!!!!!!!!!
      👍️0
      Dumb&dumber4long Dumb&dumber4long 20 hours ago
      EOD Friday 134.55 million shares short
      👍️0
      cardmaster114 cardmaster114 1 day ago
      The entire amount of outstanding shares traded in one day. Will there be a shortage of real shares? Any guess on how many synthetic shares exist?
      👍️0
      Stino2 Stino2 1 day ago
      Anyone knows how much short???
      👍️0
      glenn1919 glenn1919 1 day ago
      TNXP.....................https://stockcharts.com/h-sc/ui?s=TNXP&p=W&b=5&g=0&id=p86431144783
      👍️0
      Value_Investor Value_Investor 2 days ago
      TNXP has the average price target $53.5 while the high-end target is $96.00 and the low-end target is $11.00 --- see the link below!

      https://www.marketbeat.com/stocks/NASDAQ/TNXP/forecast/

      My goal is to accumulate at least 1,869,159 shares before the Key FDA-Approval Day August 15, 2025 because those shares will be worthy $100,000,006, $179,439,264, and $20,560,749 respectively based on the above-mentioned three targets!

      Next week this Hidden Gem should test price area $1.3 ~ $0.72 again...

      😝 1 🤣 2
      green maschine green maschine 2 days ago
      Looks ready to do that soon.
      👎️ 1
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      Only if it takes out today’s high, the next hurdle.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      What works for you best, keep it up.
      Your price target is reasonable for you, as of now.
      Adjust, as the situation changes.
      Don’t early out!
      I will surely be left behind.
      Good luck.
      👍️0
      timberwolf7 timberwolf7 2 days ago
      The sec under gentsler has been WORTHLESS when it comes to
      enforcement, and naked shorting in particular...

      There was a guy (whistleblower) who worked on Wall Street. Who in the last
      6 months or so was out saying, wall street knows its illegal, yet they
      not only allow the trading to happen, they do it themselves.

      And he said the sec is just looking the other way.

      Why its good to see gentsler leaving. Now the question is, with so much
      questionable activity/corruption taking place on wall street, what will the
      new guy be able to do. And wonder WHO will be leading the charge to
      clean up the insider trading taking place within the fed government..

      Who will they send to jail, if anyone..
      👍️0
      timberwolf7 timberwolf7 2 days ago
      On the 'past chart' vs future projections:

      I don't put any 'faith' in what 'was' IF something radical
      in their fundamentals changed. That just happened for me
      with the fdas acceptance of their submission. This just
      changed the companies profile, and how the market is now
      looking at it, will look at it. And they will now assign a value
      on the new circumstances when defining its 'worth'.

      So the only part of the chart I use anymore is the part involved in
      the current 'basing move' (when it started for duration purposes)
      and what its now doing. Yep, once the company dynamics are 'upset'/
      radically changed, what was, no longer 'is'...

      And I am primarily a buy & hold investor myself. Thinking $3 would be a
      good target price based on its current share loading (ie, market cap). While
      that will be a great price to see, anything above that will be the icing on the
      proverbial cake...
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      To all who care, go to Tonix official site, select Contact us, & file a similar request;
      The Company should have a bigger concern than us, the shareholders!
      Remember the “don’t underestimate the power of shareholders by the numbers”
      Let’s make it count, spread the request around.

      “To the CEO & all whom it may be of concern.
      in accordance with SEC, Naked short selling (selling without borrowing the securities) is banned.
      It is illegal, however, naked short selling on TNXP stock is rampant.
      According to FINTRA reporting on December 16th, short interest was 916.606 million shares, far exceeding the number of the 186.6 million outstanding share.
      I believe Tonix has responsibility to put a stop to this well-known illegal naked short selling.
      I filed a complaint weeks ago, but I believe a complaint by Company Tonix will have much more impact.
      Please pursue a stop to naked short selling on your company stock.
      It would be greatly appreciated by Tonix shareholders”
      👍️0
      cardmaster114 cardmaster114 2 days ago
      Looks like the entire outstanding shares will turn over today. We should break your target of .426.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      It needs to surpass 0.426
      👍️ 1
      cardmaster114 cardmaster114 2 days ago
      Buying of shares is increasing to sold shares. Covering is increasing.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      Schwab shows only 1.98% of shares held by institutions!
      Marketbeat.com says 82.26% held by institutions!
      WTF is with Schwab!
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      tnxp ended yesterday with 101.2 million shares short.
      How many shorts lost them ⚽️s today!
      Will see this evening.
      Sometimes, the more shorts the better, to squeeze them harder in good time.
      👍️ 1
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      Nothing is wrong tracking shorter time frame chart.
      The long term trend is by long term chart.
      4long trend, I use yr/day chart.
      It’s looking better.
      Not interested in getting in & out.
      Long term capital gain.
      👍️0
      Stino2 Stino2 2 days ago
      Strange I want to sell also at 4$ 😃
      👍️ 1 😃 1
      cardmaster114 cardmaster114 2 days ago
      One dollar is coming soon. Shorts are covering at a faster pace. I expect a PR from the company soon.
      👍️ 2 😃 1
      INV4 INV4 2 days ago
      I like number 4 (4=$) 😄
      0,4
      $TNXP
      👍️0
      INV4 INV4 2 days ago
      Nice day! 😃

      $TNXP
      👍️0
      Frankestin Frankestin 2 days ago
      0,4
      👍️ 1 😃 1
      Stino2 Stino2 2 days ago
      40 cent Yes we can 😃
      👍️ 2 😃 1
      Frankestin Frankestin 2 days ago
      dedicated to those who sell it
      👍️ 1
      timberwolf7 timberwolf7 2 days ago
      Market moves too fast, folks should consider shortening up the times
      used on your chart.

      Did it years ago (around 2010 timeframe) myself..
      will only say I use a number less than 20 Days for my MA
      for example..

      Works well in most cases to reflect the changes.

      But for something really volatile? Not fast enough and I
      can't go any shorter in my timeframe cause the predictability
      isn't reliable.

      No longer rely on a weekly scale chart either.. for predicting..
      what may happen next...
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      What does this site have to do with tnxp!
      👍️0
      INV4 INV4 2 days ago
      Looks good here the last few days 💹
      Have a nice weekend everyone!

      $TNXP
      👍️0
      Stino2 Stino2 2 days ago
      High volumes, it is going the good way up up up
      👍️ 2
      Frankestin Frankestin 2 days ago
      https://app.filmora.io/#/object/cu9q03stmqn905j75qpg?source=%7B%22product_id%22:%227616%22,%22product_page%22:%22share_url%22,%22product_version%22:%2214.3.2.11147%22%7D
      👍️0
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      Agree.
      I prefer to use the 1 year/day chart.
      It traded above the 150 MA yesterday but closed below it.
      150 MA is going flat from a deep dive, looking for it to slope up.
      20 MA needs to get back upward.
      The top goal is to cross the 200 MA, which would be 1st time in many years.
      Patience
      👍️ 3
      Dumb&dumber4long Dumb&dumber4long 2 days ago
      It’s history.
      Focus on the way forward.
      With what we know now, & going forward, that was a cheap shot comments.
      Good luck
      👍️0
      Frankestin Frankestin 2 days ago
      Exactly for this reason!
      Same same but different... this time it will disappoint the shorties, who are likely retailers. If history repeats itself, we’re heading above 1 before the game changes. IMO
      👍️ 1
      3jack 3jack 2 days ago
      Tonix never ever fails to disappoint. Just look at its history.
      👍️0
      glenn1919 glenn1919 2 days ago
      TNXP..................................https://stockcharts.com/h-sc/ui?s=TNXP&p=W&b=5&g=0&id=p86431144783
      👍️ 3
      timberwolf7 timberwolf7 3 days ago
      Share price has climbed back thru the Moving Ave line (overhead resistance)

      Given there is a reason to consider owning shares?? Will the MA line now
      act as SUPPORT for the share price, help 'guide' it higher (as the MA line
      has also developed a positive slope as of yesterdays close)
      👍️0
      Dumb&dumber4long Dumb&dumber4long 3 days ago
      Some shorts cover.
      Yesterday 159.6 million shares short.
      Today down to 101.2 million shares short.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 3 days ago
      EOD 1/22/25 shorts amount to 159.6 million shares
      Now 1/23/25 shorts amounts to 101.2 million shares.
      Some shorts cover
      Not near as bad as Dec 18th/19th, near 800 million shares
      👍️ 1
      Viewmont Viewmont 3 days ago
      $TNXP Did pretty good!
      👍️ 1
      insidernews insidernews 3 days ago
      What one sells the other buys
      👍️ 1
      timberwolf7 timberwolf7 3 days ago
      On IMC 1 trial. They haven't started it yet, its looking like a year to run it, and the time to
      set it up, initiate it, data scrub and then file?

      TNXP has a big lead so at this point, really don't care what they are doing..
      Just wondering how many are going to end up taking losses or holding expensive shares
      when reality and fundamentals settle back into control of their share price.
      👍️0
      richme richme 3 days ago
      That usually means flippers churning for a couple of ticks at the moment. Especially true of large holders who make a living from flipping stocks.
      👍️0
      cardmaster114 cardmaster114 3 days ago
      144 million shares traded with 186 million share float ? Entire float flipping over again.
      👍️0
      Dumb&dumber4long Dumb&dumber4long 3 days ago
      IMC-1, a combination of femciclovir & celecoxib is designed to suppress herbs & reduce fibromyalgia symptoms.
      Not targeting fibromyalgia specifically!
      Will look more into the drug.
      & no guarantee phase 3 success.
      Tnxp passed phase 3 two times.
      👍️0

      Your Recent History

      NASDAQ
      TNXP
      Tonix Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads